Explanatory note: Order Respecting Certain Time Limits under the Food and Drug Regulations (COVID-19) (English, HTML)

View metadata and access the original English HTML file: Explanatory note: Order Respecting Certain Time Limits under the Food and Drug Regulations (COVID-19).

Format

HTML

Access

file-only

Publisher-reported update

2023-11-01

The objective of this Ministerial Order is to ensure that Health Canada is able to review all applications for new clinical trials or amendments to ongoing trials within the default period, by extending the default review period for clinical trial submissions and amendments to 45 days, from 30 days.

Access original file